arginyl-glycyl-aspartic acid has been researched along with Central Retinal Edema, Cystoid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beets, K; Etienne, I; Feyen, JHM; Hu, TT; Stitt, AW; Van Bergen, T; Van Hove, I; Vermassen, E | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Diabetes Mellitus; Diabetic Retinopathy; Humans; Integrins; Macular Edema; Oligopeptides; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |